Synthesis of deuterium‐labeled crizotinib, a potent and selective dual inhibitor of mesenchymal‐epithelial transition factor (c‐MET) kinase and anaplastic lymphoma kinase (ALK).

Autor: Ao, Wangwei1, Li, Yuan1, Zhang, Yinsheng1 zys@cttq.com
Zdroj: Journal of Labelled Compounds & Radiopharmaceuticals. Dec2018, Vol. 61 Issue 14, p1036-1042. 7p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje